Literature DB >> 22431719

Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.

Krasimira Aleksandrova1, Heiner Boeing, Mazda Jenab, H Bas Bueno-de-Mesquita, Eugene Jansen, Fränzel J B van Duijnhoven, Veronika Fedirko, Sabina Rinaldi, Isabelle Romieu, Elio Riboli, Dora Romaguera, Sabine Westphal, Kim Overvad, Anne Tjønneland, Marie Christine Boutron-Ruault, Françoise Clavel-Chapelon, Rudolf Kaaks, Annekatrin Lukanova, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Claudia Agnoli, Amalia Mattiello, Calogero Saieva, Paolo Vineis, Rosario Tumino, Petra H Peeters, Marcial Argüelles, Catalina Bonet, María-José Sánchez, Miren Dorronsoro, Jose-María Huerta, Aurelio Barricarte, Richard Palmqvist, Göran Hallmans, Kay-Tee Khaw, Nick Wareham, Naomi E Allen, Francesca L Crowe, Tobias Pischon.   

Abstract

Adiponectin-an adipose tissue-derived protein-may provide a molecular link between obesity and colorectal cancer (CRC), but evidence from large prospective studies is limited. In particular, no epidemiological study explored high-molecular weight (HMW) and non-HMW adiponectin fractions in relation to CRC risk, despite them being hypothesized to have differential biological activities, i.e. regulating insulin sensitivity (HMW adiponectin) versus inflammatory response (non-HMW adiponectin). In a prospective, nested case-control study, we investigated whether prediagnostic serum concentrations of total, HMW and non-HMW adiponectin are associated with risk of CRC, independent of obesity and other known CRC risk factors. A total of 1206 incident cases (755 colon and 451 rectal) were matched to 1206 controls using incidence-density sampling. In conditional logistic regression, adjusted for dietary and lifestyle factors, total adiponectin and non-HMW adiponectin concentrations were inversely associated with risk of CRC [relative risk (RR) comparing highest versus lowest quintile = 0.71, 95% confidence interval (CI) = 0.53-0.95, P(trend) = 0.03 for total adiponectin and RR = 0.45, 95% CI = 0.34-0.61, P(trend) < 0.0001 for non-HMW adiponectin]. HMW adiponectin concentrations were not associated with CRC risk (RR = 0.91, 95% CI = 0.68-1.22, P(trend) = 0.55). Non-HMW adiponectin was associated with CRC risk even after adjustment for body mass index and waist circumference (RR = 0.39, 95% CI = 0.26-0.60, P(trend) < 0.0001), whereas the association with total adiponectin was no longer significant (RR = 0.81, 95% CI = 0.60-1.09, P(trend) = 0.23). When stratified by cancer site, non-HMW adiponectin was inversely associated with both colon and rectal cancer. These findings suggest an important role of the relative proportion of non-HMW adiponectin in CRC pathogenesis. Future studies are warranted to confirm these results and to elucidate the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431719      PMCID: PMC3388489          DOI: 10.1093/carcin/bgs133

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  41 in total

1.  The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.

Authors:  Z Kovacova; M Tencerova; B Roussel; Z Wedellova; L Rossmeislova; D Langin; J Polak; V Stich
Journal:  Int J Obes (Lond)       Date:  2011-12-06       Impact factor: 5.095

2.  Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year.

Authors:  Tobias Pischon; Gökhan S Hotamisligil; Eric B Rimm
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

Review 3.  Adiponectin: more than just another fat cell hormone?

Authors:  Manju Chandran; Susan A Phillips; Theodore Ciaraldi; Robert R Henry
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

4.  Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.

Authors:  A Young Kim; Yun Sok Lee; Kang Ho Kim; Jae Ho Lee; Hee Kyu Lee; Su-Hwa Jang; Seong-Eun Kim; Gha Young Lee; Joo-Won Lee; Sung-Ae Jung; Hee Yong Chung; Sunjoo Jeong; Jae Bum Kim
Journal:  Mol Endocrinol       Date:  2010-05-05

5.  Adiponectin and breast cancer risk.

Authors:  Christos Mantzoros; Eleni Petridou; Nick Dessypris; Charilaos Chavelas; Maria Dalamaga; Delia Marina Alexe; Yannis Papadiamantis; Christos Markopoulos; Evangelos Spanos; George Chrousos; Dimitrios Trichopoulos
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

6.  Association of adiponectin multimers with Barrett's oesophagus.

Authors:  J H Rubenstein; J Y Kao; R D Madanick; M Zhang; M Wang; M B Spacek; J L Donovan; S D Bright; N J Shaheen
Journal:  Gut       Date:  2009-06-30       Impact factor: 23.059

Review 7.  Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Shanshan Li; Hyun Joon Shin; Eric L Ding; Rob M van Dam
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

8.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

9.  Systemic fate of the adipocyte-derived factor adiponectin.

Authors:  Nils Halberg; Todd D Schraw; Zhao V Wang; Ja-Young Kim; James Yi; Mark P Hamilton; Kate Luby-Phelps; Philipp E Scherer
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

10.  Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition.

Authors:  Sabina Rinaldi; Sabine Rohrmann; Mazda Jenab; Carine Biessy; Sabina Sieri; Domenico Palli; Rosario Tumino; Amalla Mattiello; Paolo Vineis; Alexandra Nieters; Jakob Linseisen; Tobias Pischon; Heiner Boeing; Göran Hallmans; Richard Palmqvist; Jonas Manjer; Elisabet Wirfält; Francesca L Crowe; Kay-Tee T Khaw; Sheila Bingham; Anne Tjønneland; Anja Olsen; Kim Overvad; Eiliv Lund; Guri Skeie; Francoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Blandine de Lauzon-Guillain; Eva Ardanaz; Paula Jakszyn; Jose Ramon Quiros; Maria-Dolores Chirlaque; Maria-Jose Sanchez; Miren Dorronsoro; Antonia Trichopoulou; Pagona Lagiou; Dimitrious Trichopoulos; H Bas Bueno-de-Mesquita; Fränzel J B van Duijnhoven; Petra H M Peeters; Nadia Slimani; Pietro Ferrari; Graham B Byrnes; Elio Riboli; Rudolf Kaaks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

View more
  36 in total

1.  A Prospective Analysis of Plasma Adiponectin and Risk of Incident Cancer: The Dallas Heart Study.

Authors:  Muhammad Shaalan Beg; Sadia Saleem; Aslan Turer; Colby Ayers; James A de Lemos; Amit Khera; Philipp E Scherer; Susan G Lakoski
Journal:  J Natl Compr Canc Netw       Date:  2015-07       Impact factor: 11.908

2.  Association of adulthood weight gain with circulating adipokine and insulin resistance in the Japanese population.

Authors:  Y Kimura; N M Pham; K Yasuda; A Nanri; K Kurotani; K Kuwahara; S Akter; M Sato; H Hayabuchi; T Mizoue
Journal:  Eur J Clin Nutr       Date:  2014-12-03       Impact factor: 4.016

3.  Prediction of Circulating Adipokine Levels Based on Body Fat Compartments and Adipose Tissue Gene Expression.

Authors:  Stefan Konigorski; Jürgen Janke; Dagmar Drogan; Manuela M Bergmann; Johannes Hierholzer; Rudolf Kaaks; Heiner Boeing; Tobias Pischon
Journal:  Obes Facts       Date:  2019-11-07       Impact factor: 3.942

4.  Association between plasma adiponectin levels and colorectal cancer risk in women.

Authors:  Paulette D Chandler; Julie E Buring; JoAnn E Manson; M V Moorthy; Shumin Zhang; I-Min Lee; Jennifer H Lin
Journal:  Cancer Causes Control       Date:  2015-05-05       Impact factor: 2.506

Review 5.  Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.

Authors:  Małgorzata Muc-Wierzgoń; Ewa Nowakowska-Zajdel; Sylwia Dzięgielewska-Gęsiak; Teresa Kokot; Katarzyna Klakla; Edyta Fatyga; Elżbieta Grochowska-Niedworok; Dariusz Waniczek; Janusz Wierzgoń
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 6.  Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.

Authors:  Katherine Esposito; Paolo Chiodini; Annalisa Capuano; Giuseppe Bellastella; Maria Ida Maiorino; Concetta Rafaniello; Demosthenes B Panagiotakos; Dario Giugliano
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

7.  Genetic variants of adiponectin and risk of colorectal cancer.

Authors:  Mingyang Song; Jian Gong; Edward L Giovannucci; Sonja I Berndt; Hermann Brenner; Jenny Chang-Claude; Keith R Curtis; Tabitha A Harrison; Michael Hoffmeister; Li Hsu; Shuo Jiao; Loic Le Marchand; John D Potter; Robert E Schoen; Daniela Seminara; Martha L Slattery; Emily White; Kana Wu; Shuji Ogino; Charles S Fuchs; David J Hunter; Shelley S Tworoger; Frank B Hu; Eric Rimm; Majken Jensen; Ulrike Peters; Andrew T Chan
Journal:  Int J Cancer       Date:  2014-12-08       Impact factor: 7.396

8.  Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.

Authors:  Kentaro Inamura; Mingyang Song; Seungyoun Jung; Reiko Nishihara; Mai Yamauchi; Paul Lochhead; Zhi Rong Qian; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Atsuhiro Masuda; Yu Imamura; Xuehong Zhang; Michael N Pollak; Christos S Mantzoros; Curtis C Harris; Edward Giovannucci; Charles S Fuchs; Eunyoung Cho; Andrew T Chan; Kana Wu; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2015-11-23       Impact factor: 13.506

Review 9.  Adiponectin and colorectal cancer.

Authors:  Kensuke Otani; Soichiro Ishihara; Hironori Yamaguchi; Koji Murono; Koji Yasuda; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa; Toshiaki Watanabe
Journal:  Surg Today       Date:  2016-04-09       Impact factor: 2.549

10.  Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study.

Authors:  Mingyang Song; Xuehong Zhang; Kana Wu; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2013-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.